Welcome to MCL!

This is the Consortium for Molecular and Cellular Characterization of Screen-Detected Lesions.

The MCL Consortium consists of independent, multi-disciplinary teams that undertake comprehensive molecular and cellular characterizations of tumor tissue, cell, and microenvironment components to distinguish screen-detected early lesions from interval and symptom-detected cancers.

If you'd like to join us, fill out the registration form.

 


 

COMING UP SOON:

MCL 4th Semiannual Steering Committee Meeting

The MCL Consortium will hold its 4th Face-to-Face Steering Committee Meeting at the UCLA Luskin Conference Center in Los Angeles, California from September 26 - 28.  For more information contact Judi Forman, MPH

Draft Agenda Coming Soon

 

CLICK HERE TO REGISTER FOR THE MEETING